Angiotensin converting enzyme DD genotype is associated with acute coronary syndrome severity and sudden cardiac death in Taiwan: A case-control emergency room study

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Chen, Ying Hsin ^a,b   Liu, Jui Ming ^c   Hsu, Ren Jun ^b   Hu, Sheng Chuan ^a   Harn, Horng Jyh ^d   Chen, Shee Ping ^e   Jeng, Jing Ren ^a   Wu, Chieh Lin ^b   Ho, Jar Yi ^b,f   Yu, Cheng Ping ^b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^f NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Acute coronary syndrome; Angiotensin converting enzyme; Genotype; Pharmacogenomics; Sudden cardiac death

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANGIOTENSIN CONVERTING ENZYME GENE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEART DEATH; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; MUTATOR GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUDDEN DEATH; TAIWAN; AGED; CASE CONTROL STUDY; EMERGENCY HEALTH SERVICE; GENETIC POLYMORPHISM; GENETICS; HEART INFARCTION; MIDDLE AGED; MORTALITY; RISK FACTOR;

DIPEPTIDYL CARBOXYPEPTIDASE;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DEATH, SUDDEN, CARDIAC; EMERGENCY SERVICE, HOSPITAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; TAIWAN;

EID: 84857001552     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-6     Document Type: Article

References (36)

1. Ruff CT, Braunwald E. The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol 2011, 8:140-147. 10.1038/nrcardio.2010.199, 21173793.
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001, 104:2746-2753. 10.1161/hc4601.099487, 11723030.
3. Global Burden of Disease and Risk Factors 2006, New York: Oxford University Press and The World Bank, Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ.
4. Friedlander Y, Siscovick DS, Arbogast P, Psaty BM, Weinmann S, Lemaitre RN, et al. Sudden death and myocardial infarction in first degree relatives as predictors of primary cardiac arrest. Atherosclerosis 2002, 162:211-216. 10.1016/S0021-9150(01)00701-8, 11947916.
5. Antman EM. General hospital management. Management of acute myocardial infarction 1994, 29-70. London: W.B. Saunders, Julian D, Braunwald E.
6. Ganz P, Ganz W. Coronary blood flow and myocardial ischemi. Braunwald's heart disease: a textbook of cardiovascular medicine 2001, 1118-1144. Philadelphia: Saunders Elsevier, Braunwald E, Zipes DP, Libby P, 6.
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346. 10.1172/JCI114844, 296868, 1976655.
8. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992, 51:197-205. 1682892, 1319114.
9. Danser AHJ, Schalekamp MADH, Bax WA, Van den-Brink AM, Saxena PR, Riegger GAJ, et al. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995, 92:1387-1388.
10. Keavney B, McKenzie C, Parish S, Palmer A, Clark S, Youngman L, et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000, 355(9202):434-442. 10.1016/S0140-6736(00)82009-7, 10841123.
11. Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995, 333(25):1670-1676. 10.1056/NEJM199512213332503, 7477219.
12. Zintzaras E, Raman G, Kitsios G, Lau J. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a metaanalysis. Arch Intern Med 2008, 168:1077-1089. 10.1001/archinte.168.10.1077, 18504336.
13. Harn HJ, Chang CY, Ho LI, Liu CA, Jeng JR, Lin FG, et al. Evidence that polymorphism of the angiotensin I converting enzyme enzyme gene may be raleted to idiopathic dilated cardiomyopathy in the Chinese population. Biochem Mol boil Int 1995, 35:1175-1181.
14. Lindpaintner K, Pfeller A, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evluation of an angiotensin-converting-enzyme gene polymorpohism and the risk of ischemic heart disease. N Engl J Med 1995, 332:706-711. 10.1056/NEJM199503163321103, 7854377.
15. Samani NJ, Martin DS, Brack M, Cullen J, Chauhan A, Lodwich D, et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet 1995, 345:1013-1016. 10.1016/S0140-6736(95)90756-4, 7723497.
16. Zee RYL, Solomon SD, Ajani UA, Pfeffer MA, Lindpaintner K. A prospective evaluation of the angiotensin-converting enzyme D/I polymorphism and left ventricular remodeling in the 'Healing and Early Afterload Reducing Therapy' Study. Clin Genet 2002, 61:21-25. 10.1034/j.1399-0004.2002.610104.x, 11903350.
17. Keavney B, McKenzie C, Parish S, Palmer A, Clark S, Youngman L, et al. International Studies of Infarct Survival (ISIS) Collaborators. Large-scale test of hypothesized associations between the angiotensin-converting- enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet 2000, 355:434-442.
18. Sotoodehnia N, Li G, Johnson CO, Lemaitre RN, Rice KM, Rea TD, Siscovick DS. Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk. Heart Rhythm 2009, 6:1306-1314. 10.1016/j.hrthm.2009.06.013, 2757102, 19716087.
19. Wu CK, Luo JL, Wu XM, Tsai CT, Lin JW, Hwang JJ, et al. A propensity score-based case-control study of renin-angiotensin system gene polymorphisms and diastolic heart failure. Atherosclerosis 2009, 205:497-502. 10.1016/j.atherosclerosis.2008.12.033, 19185300.
20. American Heart Association Committee Report: a reporting system on patients evaluated for coronary artery disease. Circulation 1975, 51:7. American Heart Association.
21. Trost JC, Lange RA. Treatment of acute coronary syndrome: Part 1: Non-ST-segment acute coronary syndrome. Crit Care Med 2011, 39:2346-2353. 10.1097/CCM.0b013e31821e855f, 21602671.
22. Namazi S, Monabati A, Ardeshir-Rouhani-Fard S, Azarpira N. Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in Iranian population. Mol Carcinog 2010, 49:1022-1030. 10.1002/mc.20685, 20945417.
23. Lau JF, Weinberg MD, Olin JW. Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis. Nat Rev Cardiol 2011, 8:405-418. 10.1038/nrcardio.2011.66, 21629211.
24. Yao S. Myocardial repair/remodeling following infarction: roles of local factors. Cardiovasc Res 2009, 81:482-490. 2639132, 19050008.
25. Pfohl M, Koch M, Prescod S, Haase KK, Häring HU, Karsch KR. Angiotensin I- converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study. Eur Heart J 1999, 20:1318-1325. 10.1053/euhj.1999.1543, 10462466.
26. Linhart A, Sedlácek K, Jáchymová M, Jindra A, Beran S, Vondrácek V, et al. Lack of association of angiotensin-converting enzyme and angiotensinogen genes polymorphisms with left ventricular structure in young normotensive men. Blood Press 2000, 9:47-51. 10.1080/080370500439425, 10854008.
27. Zucker IH, Zimmerman MC. The renin-angiotensin system in 2011: new avenues for translational research. Curr Opin Pharmacol 2011, 11:101-104. 10.1016/j.coph.2011.02.006, 21371939.
28. Jeunemaitre X, Ledru F, Battaglia S, Guillanneuf MT, Courbon D, Dumont C, et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet 1997, 99:66-73.
29. Vaisi-Raygani A, Ghaneialvar H, Rahimi Z, Nomani H, Saidi M, Bahrehmand F, et al. The angiotensin converting enzyme D allele is an independent risk factor for early onset coronary artery disease. Clin Biochem 2010, 43:1189-1194. 10.1016/j.clinbiochem.2010.07.010, 20655894.
30. Igić R, Behnia R. Properties and distribution of angiotensin I converting enzyme. Curr Pharm Des 2003, 9:697-706. 10.2174/1381612033455459, 12570787.
31. Yang Q, Khoury MJ. Evolving methods in genetic epidemiology III. Gene-environment interaction in epidemiologic research. Epidemiol Rev 1997, 19:33-43.
32. Parenica J, Goldbergova MP, Kala P, Jarkovsky J, Poloczek M, Manousek J, et al. ACE gene insertion/deletion polymorphism has a mild influence on the acute development of left ventricular dysfunction in patients with ST elevation myocardial infarction treated with primary PCI. BMC Cardiovasc Disord 2010, 10:60. 10.1186/1471-2261-10-60, 3022786, 21162760.
33. Mondry A, Loh M, Liu P, Zhu AL, Nagel M. Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrol 2005, 6:1. 10.1186/1471-2369-6-1, 546009, 15642127.
34. Niu W, Qi Y, Gao P, Zhu D. Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis. Endocr J 2010, 57:431-438. 10.1507/endocrj.K09E-360, 20160398.
35. Scharplatz M, Puhan MA, Steurer J, Bachmann LM. What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors?-Protocol of a systematic review. BMC Med Genet 2004, 5:23. 518966, 15361261.
36. Kessels AG, Severens JL. Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor. Pharmacogenet Genomics 2007, 17:359-368. 10.1097/01.fpc.0000236336.34175.e8, 17429318.